Reviva Pharmaceuticals Holdings Inc [NASDAQ: RVPH] stock went on an upward path that rose over 10.82% on Tuesday, amounting to a one-week price increase of more than 24.63%.
Over the last 12 months, RVPH stock dropped by -61.75%. The one-year Reviva Pharmaceuticals Holdings Inc stock forecast points to a potential upside of 86.2. The average equity rating for RVPH stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $79.66 million, with 115.06 million shares outstanding and 109.15 million shares in the current float. Compared to the average trading volume of 10.07M shares, RVPH stock reached a trading volume of 9316228 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Reviva Pharmaceuticals Holdings Inc [RVPH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RVPH shares is $5.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RVPH stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Chardan Capital Markets have made an estimate for Reviva Pharmaceuticals Holdings Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 29, 2025. While these analysts kept the previous recommendation, ROTH MKM raised their target price to Buy. The new note on the price target was released on September 20, 2023, representing the official price target for Reviva Pharmaceuticals Holdings Inc stock. Previously, the target price had yet another raise to $17, while The Benchmark Company analysts kept a Speculative Buy rating on RVPH stock.
The Price to Book ratio for the last quarter was 14.66, with the Price to Cash per share for the same quarter was set at 0.11.
RVPH Stock Performance Analysis:
Reviva Pharmaceuticals Holdings Inc [RVPH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 24.63. With this latest performance, RVPH shares gained by 37.31% in over the last four-week period, additionally sinking by -17.58% over the last 6 months – not to mention a drop of -61.75% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RVPH stock in for the last two-week period is set at 63.82, with the RSI for the last a single of trading hit 0.0557, and the three-weeks RSI is set at 0.0612 for Reviva Pharmaceuticals Holdings Inc [RVPH]. The present Moving Average for the last 50 days of trading for this stock 0.5694, while it was recorded at 0.6238 for the last single week of trading, and 0.6637 for the last 200 days.
Reviva Pharmaceuticals Holdings Inc (RVPH) Capital Structure & Debt Analysis
According to recent financial data for Reviva Pharmaceuticals Holdings Inc. ( RVPH), the Return on Equity (ROE) stands at -916.17%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -207.23%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Reviva Pharmaceuticals Holdings Inc’s Return on Invested Capital (ROIC) is -500.18%, showcasing its effectiveness in deploying capital for earnings.
Reviva Pharmaceuticals Holdings Inc (RVPH) Efficiency & Liquidity Metrics
Based on Reviva Pharmaceuticals Holdings Inc’s (RVPH) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Reviva Pharmaceuticals Holdings Inc (RVPH) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Reviva Pharmaceuticals Holdings Inc. (RVPH) effectively leverages its workforce, generating an average of -$1625714.29 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.39% and a Quick Ratio of 1.39%, indicating strong ability to cover short-term liabilities.
RVPH Stock EPS
With the latest financial reports released by the company, Reviva Pharmaceuticals Holdings Inc posted -0.15/share EPS, while the average EPS was predicted by analysts to be reported at -0.22/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.07. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for RVPH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Reviva Pharmaceuticals Holdings Inc go to 34.97%.
Reviva Pharmaceuticals Holdings Inc [RVPH] Institutonal Ownership Details
There are presently around $8.35%, or 8.72%% of RVPH stock, in the hands of institutional investors. The top three institutional holders of RVPH stocks are: WOODLINE PARTNERS LP with ownership of 1.59 million shares, which is approximately 5.2129%. MILLENNIUM MANAGEMENT LLC, holding 1.24 million shares of the stock with an approximate value of $$1.59 million in RVPH stocks shares; and MILLENNIUM MANAGEMENT LLC, currently with $$1.31 million in RVPH stock with ownership which is approximately 3.3554%.
